glp-1 weight loss drugs tirzepatide semaglutide Decoding Medications The ABC's of GLP-1s: Benefits,
Description
This case highlights the need for gradual insulin tapering and close monitoring while transitioning from insulin therapy to GIP/GLP-1 receptor agonists.
Working with George Karavetsos, former director of FDA's Office of Criminal...
Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S
Little is known about the association of discontinuation of sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RA) with outcomes in patients with CKD
Click here to know more.
Primary outcomes included serious adverse events and retained gastric products based on patient records, procedure reports, and procedural videos
